Skip to main content

Advertisement

SpringerLink
Log in

Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients

  • Pharmacogenetics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

This exploratory study was aimed at elucidating the pharmacogenetics of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) and their implications on docetaxel pharmacokinetics and pharmacodynamics in local Chinese nasopharyngeal cancer patients.

Methods

A total of 59 single nucleotide polymorphisms (SNPs), including tag-SNPs and functionally relevant SNPs of the genes encoding these regulatory nuclear receptors (PXR/NR1I2, CAR/NR1I3, RXRα/NR2B1 and HNF4α/NR2A1), were profiled in the patients enrolled in our study by direct sequencing (N = 50). The generalized linear model was employed to estimate the haplotypic effects on the pharmacokinetics and pharmacodynamics of the patients.

Results

The pharmacokinetic profiles of docetaxel in these patients were characterized by marked interindividual variability, with approximately four- to sixfold variations observed in Cmax, AUC0-∞ and CL. Individual SNP association tests revealed that polymorphisms in NR2B1 and NR2A1 were significantly correlated with altered docetaxel pharmacokinetics. Subsequent haplotype association analysis identified the NR2B1 LD block 2 AG haplotype [*+4458G>A(rs3132291) and *+4988A>G(rs4842198)] to be significantly associated with altered pharmacokinetics, in which patients carrying two copies of the AG haplotype had approximately a 20 % decreased Cmax and AUC0-∞ and a 21 % increased CL compared to those who carried only one copy or no copies of the haplotype. A number of SNPs in NR1I2, NR1I3, NR2B1 and NR2A1 were also associated with a significant decrease in blood counts from baseline. No haplotype was found to exert any effects on the pharmacodynamics parameters.

Conclusions

The present exploratory study identified several SNPs in the genes encoding regulatory nuclear receptors which may account for the interpatient variability in docetaxel pharmacokinetics and pharmacodynamics. These findings highlight the important role of regulatory nuclear receptors on the disposition of docetaxel.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rudek MA, Sparreboom A, Garrett-Mayer ES, Armstrong DK, Wolff AC, Verweij J, Baker SD (2004) Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy. Eur J Cancer 40:1170–1178

    Article  CAS  PubMed  Google Scholar 

  2. Shou M, Martinet M, Korzekwa KR, Krausz KW, Gonzalez FJ, Gelboin HV (1998) Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver. Pharmacogenetics 8:391–401

    Article  CAS  PubMed  Google Scholar 

  3. Smith NF, Acharya MR, Desai N, Figg WD, Sparreboom A (2005) Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel. Cancer Biol Ther 4:815–818

    Article  CAS  PubMed  Google Scholar 

  4. Bardelmeijer HA, Ouwehand M, Buckle T, Huisman MT, Schellens JHM, Beijnen JH, van Tellingen O (2002) Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir. Cancer Res 62:6158–6164

    CAS  PubMed  Google Scholar 

  5. Chew S-C, Singh O, Chen X, Ramasamy RD, Kulkarni T, Lee EJD, Tan E-H, Lim W-T, Chowbay B (2011) The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. Cancer Chemother Pharmacol 67:1471–1478

    Article  CAS  PubMed  Google Scholar 

  6. Chew SC, Sandanaraj E, Singh O, Chen X, Tan EH, Lim WT, Lee EJD, Chowbay B (2012) Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients. Br J Clin Pharmacol 73:606–618

    Article  CAS  PubMed  Google Scholar 

  7. Bosch TM, Huitema ADR, Doodeman VD, Jansen R, Witteveen E, Smit WM, Jansen RL, van Herpen CM, Soesan M, Beijnen JH, Schellens JHM (2006) Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel. Clin Cancer Res 12:5786–5793

    Article  CAS  PubMed  Google Scholar 

  8. Xu C, Li CYT, Kong ANT (2005) Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249–268

    Article  CAS  PubMed  Google Scholar 

  9. Burk O, Koch I, Raucy J, Hustert E, Eichelbaum M, Brockmöller J, Zanger UM, Wojnowski L (2004) The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J Biol Chem 279:38379–38385

    Article  CAS  PubMed  Google Scholar 

  10. Urquhart BL, Tirona RG, Kim RB (2007) Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 47:566–578

    Article  CAS  PubMed  Google Scholar 

  11. Tirona RG, Lee W, Leake BF, Lan L-B, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, Schuetz EG, Kim RB (2003) The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9:220–224

    Article  CAS  PubMed  Google Scholar 

  12. Sandanaraj E, Lal S, Selvarajan V, Ooi LL, Wong ZW, Wong NS, Ang PCS, Lee EJD, Chowbay B (2008) PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients. Clin Cancer Res 14:7116–7126

    Article  CAS  PubMed  Google Scholar 

  13. Chew SC, Lim JSL, Lee EJD, Chowbay B (2013) Genetic Variations of < I > NR2A1</I > in Asian Populations: Implications in pharmacogenetics studies. Drug Metab Pharmacokinet 28:278–288

    Article  CAS  PubMed  Google Scholar 

  14. Chew SC, Lim JSL, Singh O, Wong M, Lee EJD, Chowbay B (2013) Genetic Variations of < I > NR1I3</I > and < I > NR2B1</I > in Asian Populations. Drug Metab Pharmacokinet 28:169–176

    Article  CAS  PubMed  Google Scholar 

  15. Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Wrighton SA, Hancock M, Kim RB, Strom S, Thummel K, Russell CG, Hudson JR, Schuetz EG, Boguski MS (2001) The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11:555–572

    Article  CAS  PubMed  Google Scholar 

  16. Zhu Q, Yamagata K, Miura A, Shihara N, Horikawa Y, Takeda J, Miyagawa J, Matsuzawa Y (2003) T130I mutation in HNF-4alpha gene is a loss-of-function mutation in hepatocytes and is associated with late-onset Type 2 diabetes mellitus in Japanese subjects. Diabetologia 46:567–573

    CAS  PubMed  Google Scholar 

  17. Ngeow J, Lim WT, Leong SS, Ang MK, Toh CK, Gao F, Chowbay B, Tan EH (2011) Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma. Ann Oncol 22:718–722

    Article  CAS  PubMed  Google Scholar 

  18. Loos WJ, Verweij J, Nooter K, Stoter G, Sparreboom A (1997) Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci App 693:437–441

    Article  CAS  Google Scholar 

  19. Xu Z, Kaplan NL, Taylor JA (2007) TAGster: efficient selection of LD tag SNPs in single or multiple populations. Bioinformatics 23:3254–3255

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Lamba J, Lamba V, Strom S, Venkataramanan R, Schuetz E (2008) Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression. Drug Metab Dispos 36:169–181. doi:10.1124/dmd.107.016600

    Article  CAS  PubMed  Google Scholar 

  21. Hor SY, Lee SC, Wong CI, Lim YW, Lim RC, Wang LZ, Fan L, Guo JY, Lee HS, Goh BC, Tan T (2008) PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients. Pharmacogenomics J 8:139–146

    Article  CAS  PubMed  Google Scholar 

  22. Schipani A, Siccardi M, D’Avolio A, Baietto L, Simiele M, Bonora S, Rodriguez Novoa S, Cuenca L, Soriano V, Chierakul N, Saguenwong N, Chuchuttaworn C, Hoskins JM, Dvorak AM, McLeod HL, Davies G, Khoo S, Back DJ, Di Perri G, Owen A (2010) Population pharmacokinetic modeling of the association between 63396C- > T pregnane X receptor polymorphism and unboosted atazanavir clearance. Antimicrob Agents Chemother 54:5242–5250. doi:10.1128/AAC.00781-10

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Urano T, Usui T, Shiraki M, Ouchi Y, Inoue S (2009) Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density. Geriatr Gerontol Int 9:235–241

    Article  PubMed  Google Scholar 

  24. Egan JB, Thompson PA, Ashbeck EL, Conti DV, Duggan D, Hibler E, Jurutka PW, Leroy EC, Martínez ME, Mount D, Jacobs ET (2010) Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res 70:1496–1504

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Jacobs ET, Martinez ME, Campbell PT, Conti DV, Duggan D, Figueiredo JC, Haile RW, LeRoy EC, Poynter JN, Thompson PA, Baron JA (2010) Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 31:1412–1416. doi:10.1093/carcin/bgq127

    Article  CAS  PubMed  Google Scholar 

  26. Lu Y, Ye X, Cao Y, Li Q, Yu X, Cheng J, Gao Y, Ma J, Du W, Zhou L (2011) Genetic variants in peroxisome proliferator-activated receptor gamma and retinoid X receptor alpha gene and Type 2 diabetes risk: A case–control study of a Chinese Han population. Diabetes Technol Ther 13:157–164

    Article  CAS  PubMed  Google Scholar 

  27. Karami S, Brennan P, Rosenberg PS, Navratilova M, Mates D, Zaridze D, Janout V, Kollarova H, Bencko V, Matveev V, Szeszenia-Dabrowska N, Holcatova I, Yeager M, Chanock S, Menashe I, Rothman N, Chow W-H, Boffetta P, Moore LE, Toland AE (2009) Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk. PLoS One 4:e7013

    Article  PubMed Central  PubMed  Google Scholar 

  28. Anuradha S, Radha V, Mohan V (2011) Association of novel variants in the hepatocyte nuclear factor 4A gene with maturity onset diabetes of the young and early onset type 2 diabetes. Clin Genet 80:541–549. doi:10.1111/j.1399-0004.2010.01577.x

    Article  CAS  PubMed  Google Scholar 

  29. Yokoi N, Kanamori M, Horikawa Y, Takeda J, Sanke T, Furuta H, Nanjo K, Mori H, Kasuga M, Hara K, Kadowaki T, Tanizawa Y, Oka Y, Iwami Y, Ohgawara H, Yamada Y, Seino Y, Yano H, Cox NJ, Seino S (2006) Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects. Diabetes 55:2379–2386. doi:10.2337/db05-1203

    Article  CAS  PubMed  Google Scholar 

  30. Lee SS, Cha E-Y, Jung H-J, Shon J-H, Kim E-Y, Yeo C-W, Shin J-G (2008) Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity. Hepatology 48:635–645

    Article  CAS  PubMed  Google Scholar 

  31. Jiang G, Sladek FM (1997) The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor alpha. J Biol Chem 272:1218–1225

    Article  CAS  PubMed  Google Scholar 

  32. Love-Gregory LD, Wasson J, Ma J, Jin CH, Glaser B, Suarez BK, Permutt MA (2004) A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. Diabetes 53:1134–1140

    Article  CAS  PubMed  Google Scholar 

  33. Wirsing A, Senkel S, Klein-Hitpass L, Ryffel GU, Tian B (2011) A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites. PLoS One 6:e27438

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Ramamoorthy A, Li L, Gaedigk A, Bradford LD, Benson EA, Flockhart DA, Skaar TC (2012) In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4α expression. Drug Metab Dispos 40:726–733

    Article  CAS  PubMed  Google Scholar 

  35. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265

    Article  CAS  PubMed  Google Scholar 

  36. Gabriel SB (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229

    Article  CAS  PubMed  Google Scholar 

  37. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Purcell S, Daly MJ, Sham PC (2007) WHAP: haplotype-based association analysis. Bioinformatics 23:255–256

    Article  CAS  PubMed  Google Scholar 

  39. Scherag A, Jarick I, Grothe J, Biebermann H, Scherag S, Volckmar AL, Vogel CI, Greene B, Hebebrand J, Hinney A (2010) Investigation of a genome wide association signal for obesity: synthetic association and haplotype analyses at the melanocortin 4 receptor gene locus. PLoS One 5:e13967. doi:10.1371/journal.pone.0013967

    Article  PubMed Central  PubMed  Google Scholar 

  40. Giguère V (1999) Orphan nuclear receptors: from gene to function. Endocr Rev 20:689–725. doi:10.1210/er.20.5.689

    PubMed  Google Scholar 

  41. Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh J-C, Slater S, Jurutka PW (2008) Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66:S98–112

    Article  PubMed  Google Scholar 

  42. Kölsch H, Lütjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Friedrichs S, Maier W, Heun R (2008) RXRA gene variations influence Alzheimer’s disease risk and cholesterol metabolism. J Cell Mol Med 13:589–598

    Article  Google Scholar 

  43. Mishra PJ, Humeniuk R, Longo-Sorbello GSA, Banerjee D, Bertino JR (2007) A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 104:13513–13518

    Article  CAS  PubMed  Google Scholar 

  44. Synold TW, Dussault I, Forman BM (2001) The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7:584–590. doi:10.1038/87912

    Article  CAS  PubMed  Google Scholar 

  45. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122–15127. doi:10.1074/jbc.M001215200

    Article  CAS  PubMed  Google Scholar 

  46. Motsinger AA, Ritchie MD (2006) Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies. Hum Genomics 2:318–328

    CAS  PubMed Central  PubMed  Google Scholar 

  47. Wagner-Souza K, Diamond HR, Ornellas MH, Gomes BE, Almeida-Oliveira A, Abdelhay E, Bouzas LF, Rumjanek VM (2008) Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: Comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells. Int J Mol Med 22:237–242

    CAS  PubMed  Google Scholar 

  48. Chaudhary PM, Mechetner EB, Roninson IB (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735–2739

    CAS  PubMed  Google Scholar 

  49. Chan S, Friedrichs K, Noel D, Pintér T, Van Belle S, Vorobiof D, Duarte R, Gil Gil M, Bodrogi I, Murray E, Yelle L, von Minckwitz G, Korec S, Simmonds P, Buzzi F, González Mancha R, Richardson G, Walpole E, Ronzoni M, Murawsky M, Alakl M, Riva A, Crown J, Group ftS (1999) Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol 17:2341

    CAS  PubMed  Google Scholar 

  50. Hainsworth JD (2004) Practical aspects of weekly docetaxel administration schedules. Oncologist 9:538–545

    Article  CAS  PubMed  Google Scholar 

  51. McKeage MJ (1995) Comparative adverse effect profiles of platinum drugs. Drug Saf 13:228–244

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from National Medical Research Council Singapore NMPPG11122 and NMCCG10122.

Author information

Authors and Affiliations

  1. Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, Singapore, Singapore, 117597

    Sin-Chi Chew, Joanne Lim & Edmund-JD Lee

  2. Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre, 11 Hospital Drive, Singapore, Singapore, 169610

    Sin-Chi Chew, Joanne Lim, Onkar Singh, Xiangai Chen & Balram Chowbay

  3. Department of Medical Oncology, National Cancer Centre, 11 Hospital Drive, Singapore, Singapore, 169610

    Eng-Huat Tan

  4. Office of Clinical Sciences, Duke–NUS Graduate Medical School Singapore, 8 College Road, Singapore, Singapore, 169857

    Balram Chowbay

  5. SingHealth Clinical Phamacology Core, The Academia, SingHealth, 20 College Road, The Academia, Discovery Tower, Singapore, Singapore, 169856

    Balram Chowbay

Authors
  1. Sin-Chi Chew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanne Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Onkar Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiangai Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eng-Huat Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Edmund-JD Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Balram Chowbay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Balram Chowbay.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(XLS 98 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chew, SC., Lim, J., Singh, O. et al. Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients. Eur J Clin Pharmacol 70, 155–166 (2014). https://doi.org/10.1007/s00228-013-1596-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-013-1596-3

Keywords

Search

Navigation